Evidence of pleiotropy by statins: Leukocyte Rho kinase (ROCK) activity and pretreated statin before percutaneous coronary interventions are clinical vascular outcome predictors

International Journal of Cardiology

Volumn 176, Issue 1, 2014, Pages 250-253

  Liu, Ping Yen ^a,b   Lee, Po Tseng ^a,b   Chang, Wei Ting ^a,b   Tai, Yun Ling ^a,b   Chao, Ting Hsing ^a,b   Lee, Cheng Han ^a,b   Li, Yi Heng ^a,b   Chen, Jyh Hong ^a,b   Tsai, Liang Miin ^a,b   Liao, James K ^c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Inflammation; Percutaneous coronary intervention; Rho kinase; Statin

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RHO KINASE; TROPONIN T;

ADULT; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLEIOTROPY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SMOKING; UNIVARIATE ANALYSIS; VASCULAR ENDOTHELIUM; VASODILATATION; ADVERSE EFFECTS; AGED; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; LEUKOCYTE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDICTIVE VALUE; PREOPERATIVE CARE; PROCEDURES; TREATMENT OUTCOME;

AGED; ENZYME ACTIVATION; FEMALE; GENETIC PLEIOTROPY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOCYTES; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RHO-ASSOCIATED KINASES; TREATMENT OUTCOME;

EID: 84906317827     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.059     Document Type: Article

References (16)

1. J. Herrmann, A. Lerman, and D. Baumgart et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction Circulation 106 2002 2180 2183 (Pubitemid 35222209)
2. C. Briguori, A. Colombo, and F. Airoldi et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction Eur Heart J 25 2004 1822 1828 (Pubitemid 39330233)
3. S.M. Chang, N. Yazbek, and N.M. Lakkis Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome Catheter Cardiovasc Interv 62 2004 193 197 (Pubitemid 38788696)
4. R. Merla, N.K. Reddy, F.W. Wang, B.F. Uretsky, A. Barbagelata, and Y. Birnbaum Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis Am J Cardiol 100 2007 770 776 (Pubitemid 47268265)
5. K. Noma, Y. Rikitake, and N. Oyama et al. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury J Clin Invest 118 2008 1632 1644 (Pubitemid 351632368)
6. H.W. Wang, P.Y. Liu, and N. Oyama et al. Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR -/- mice FASEB J 22 2008 3561 3570
7. M. Dong, J.K. Liao, B. Yan, R. Li, M. Zhang, and C.M. Yu A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome Int J Cardiol 167 2013 2813 2819
8. P.M. Ridker, C.P. Cannon, and D. Morrow et al. C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28 (Pubitemid 40075677)
9. S. Fichtlscherer, C. Schmidt-Lucke, and S. Bojunga et al. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy Eur Heart J 27 2006 1182 1190
10. P.Y. Liu, Y.W. Liu, L.J. Lin, J.H. Chen, and J.K. Liao Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation Circulation 119 2009 131 138
11. C.Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol Med 14 2008 37 44
12. S. Dimmeler, A. Aicher, and M. Vasa et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J Clin Invest 108 2001 391 397 (Pubitemid 32730785)
13. C.L. Chang, P.T. Lee, and W.T. Chang et al. The interplay between inflammation, physical activity and metabolic syndrome in a remote male geriatric community in Southern Taiwan: the Tianliao Old People (TOP) study 03 Diabetol Metab Syndr 5 2013 60
14. P.Y. Liu, Y.H. Li, and W.C. Tsai et al. Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention Eur Heart J 24 2003 1824 1832
15. P.Y. Liu, J.H. Chen, L.J. Lin, and J.K. Liao Increased Rho kinase activity in a Taiwanese population with metabolic syndrome J Am Coll Cardiol 49 2007 1619 1624 (Pubitemid 46551629)
16. P.Y. Liu, and J.K. Liao A method for measuring Rho kinase activity in tissues and cells Methods Enzymol 439 2008 181 189